18 research outputs found
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
<p><b>Article full text</b></p>
<p><br></p>
<p>The full text of this article can
be found here<b>. </b><a href="https://link.springer.com/article/10.1007/s40487-016-0027-x">https://link.springer.com/article/10.1007/s40487-016-0027-x</a></p><p></p>
<p><br></p>
<p><b>Provide enhanced content for this
article</b></p>
<p><br></p>
<p>If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact <a href="http://www.medengine.com/Redeem/âmailto:[email protected]â"><b>[email protected]</b></a>.</p>
<p><br></p>
<p>The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.</p>
<p><br></p>
<p>Other enhanced features include,
but are not limited to:</p>
<p><br></p>
<p>• Slide decks</p>
<p>• Videos and animations</p>
<p>• Audio abstracts</p>
<p>• Audio slides</p
Agreement between EORTC criteria and PERCIST (reader 1).
<p>Agreement between EORTC criteria and PERCIST (reader 1).</p
Baseline PET with a single target lesion (PERCIST).
<p>Blue spot corresponding to the lesion having the highest SULpeak (target lesion). As shown on this image the highest SULpeak target is located on the left lobe of the liver.</p
Baseline PET with 5 target lesions (EORTC).
<p>Blue spots corresponding to target lesions.</p
Follow up PET with a different location of the highest SULpeak target lesion (PERCIST).
<p>Blue spot corresponding to the lesion having the highest SULpeak (target lesion). This follow up scan having a different target lesion, now located on the right lobe of the liver.</p
EORTC metabolic response group definitions.
<p>EORTC metabolic response group definitions.</p
Follow up PET with new measures of the same 5 target lesions (EORTC).
<p>Blue spots corresponding to target lesions.</p
Summarised results of EORTC evaluation example.
<p>Summarised results of EORTC evaluation example.</p
PERCIST metabolic response group definitions.
<p>PERCIST metabolic response group definitions.</p
Summary of EORCT and PERCIST evaluation methods.
<p>Summary of EORCT and PERCIST evaluation methods.</p